COVERSTORY
By Ellen Amos, Maria Bavishi and Kristina Belyea
For Ferring Pharmaceuticals, 2021 was a very big year — it launched its first-to-market, FDA-approved microbiota-based live biotherapeutic, REBYOTA™. With this product’s caliber and importance, they knew that their launch strategy needed to be robust, focusing heavily on scientific content and high-engagement training if they were to meet their launch objectives.
To achieve this, Ferring sought partners who shared their “symbiotic partnerships” philosophy and found them in strategy and content provider Axiom, and learning platform provider ACTO.
Together, Ferring and its partners created an immersive product launch learning experience for the field team, built upon an engaging and strategic curriculum and a user-friendly training and event platform. The training program was quickly deployed to 150 learners, with the ability to track engagement, curriculum completion and knowledge gaps. The high engagement scores seen in Table 1 led to improved knowledge retention and behavior change.
The training program for this new product was tailored to provide enhanced stakeholder engagement at Ferring. It offered learners a comprehensive understanding of the REBYOTA™ product features, benefits and applications through a unique learning journey. This strategy aimed to ensure that all key stakeholders from commercial learning and development, marketing, sales, leadership and market access had the knowledge and tools to bring REBYOTA™ to market successfully.
This new strategy required robust scientific training content that would drive learner engagement. Ferring wanted to ensure that the content could be provided in an easy-to-digest, condensed format that would support knowledge retention and achieve launch excellence.
Finally, Ferring needed a training and events platform that was immersive and would allow learners to access bitesized training content at their convenience, making it easy to fit the training around their schedule — learning in the flow of work. Learners could complete the training at their own pace, ensuring they had enough time to absorb and understand the material. This intuitive and flexible approach added a human element to training, leading to higher engagement.
The partnership identified three fundamental needs:
Three solutions were identified and implemented to address Ferring’s needs:
The immersive training experience is an example of how thoughtful presentation of information can improve the effectiveness of training programs. The comprehensive training experience was engaging, informative and effective. The experience:
Using a creative theme of “The Journey of Care” helped sales specialists understand the complexities of the “gut microbiome” and its impact. The training program was designed to be agile and flexible to accommodate the evolving scientific lexicon. The results included:
Ferring is now in the post-launch phase of the project, and is using the data and analytics provided to identify and address any learning gaps or pull-through needs following the launch.
Ferring’s collective experience and post-launch insights include:
Ferring’s strategic collaboration perfectly exemplified a “symbiotic partnership” that resulted in the successful development and launch of its groundbreaking product. This highlights the importance of collaboration, innovation and keeping the learners top of mind to achieve training success.
Ellen Amos, ellen.amos@ferring.com, is manager, commerical training-microbiome, Ferring Pharmaceuticals.
Maria Bavishi, maria.bavishi@axiom.tceg.com, is associate scientific director, Axiom.
Kristina Belyea, kristina@actoapp.com, is director, content marketing, ACTO